Figure 2From: Evaluating real-time immunohistochemistry on multiple tissue samples, multiple targets and multiple antibody labeling methodsRT-IHC results showing RBM3 expression using fluorescently labeled secondary antibody . The binding of secondary antibody in nasopharynx (black lines) and tonsil (grey lines) after 1 h (dotted lines), 3 h (dashed lines) and 24 h (solid lines) of pre-incubation with a RBM3-binding antibody. I = Fluorescent intensity units.Back to article page